• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT MEDICAL MITRACLIP® SYSTEM STEERABLE GUIDE CATHETER; VALVE REPAIR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT MEDICAL MITRACLIP® SYSTEM STEERABLE GUIDE CATHETER; VALVE REPAIR Back to Search Results
Catalog Number UNK SGC
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Hypoxia (1918); Perforation (2001)
Event Date 09/18/2023
Event Type  Injury  
Event Description
This is filed to report a perforation.It was reported that a mitraclip procedure was performed to treat severer mitral regurgitation (mr), chronic heart failure, enlarged heart, and prolapsed mid-posterior mitral leaflet.After an atrial transseptal puncture, a slight right-to-left shunt appeared on transesophageal echocardiography.A mitraclip was implanted in the a2/p2 segment.Transesophageal echocardiography showed that the residual mr was mild without mitral stenosis.Although the mitraclip was successful, hemodynamics did not improve.Immediately after removing the steerable guide catheter (sgc), a right-to-left shunt developed continuously and there was a decrease in oxygenation.An amplatzer atrial septal defect occluder was implanted in the shunt with no reported issue.The occlusion was successful, and the oxygen increased.Despite inotropic and intra-aortic balloon pump (iabp) support, the patient remained in cardiogenic shock.Despite unloading pulmonary circulation by transcatheter mitral valve edge-to-edge repair (teer), the patient still suffered from pulmonary hypertension (ph) and right ventricular (rv) failure.When inhaled nitric acid (ino) was administered without any other additional anesthetic interventions, hemodynamics improved dramatically in few minutes.The patient was transferred from the operating room to the intensive care unit.The patient was withdrawn from iabp support on postoperative day 2.Administration of ino was stopped, and the patient was extubated on postoperative day 3.The patient was discharged from the intensive care unit on postoperative day 7 without major complications.No additional information was provided.
 
Manufacturer Narrative
B3 - date of event is estimated.D4 - the udi number is not known as the part and lot numbers were not provided.The device will not be returned for evaluation as the device was reportedly discarded.Investigation is not yet complete.A follow-up report will be submitted with all additional relevant information.
 
Manufacturer Narrative
The device was not returned for analysis.The lot history record (lhr) review was not performed because this incident was based on an article review and no lot information was provided.Based on available information, the cause of the reported perforation appears to be due to procedural conditions.The reported hypoxia appears to be a cascading effect of the reported perforation.Additionally, the reported patient effect of perforation is listed in the instructions for use and is a known possible complication associated with mitraclip procedures.The reported medical interventions were the result of case-specific circumstances.There is no indication of a product quality issue with respect to manufacture, design, or labeling.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MITRACLIP® SYSTEM STEERABLE GUIDE CATHETER
Type of Device
VALVE REPAIR
Manufacturer (Section D)
ABBOTT MEDICAL
5050 nathan lane n
plymouth MN 55442
Manufacturer (Section G)
ABBOTT VASCULAR, REG # 3005070406
3885 bohannon drive
menlo park CA 94025
Manufacturer Contact
karen krouse
5050 nathan lane n
plymouth, MN 55442
6517565400
MDR Report Key17940572
MDR Text Key325745569
Report Number2135147-2023-04519
Device Sequence Number1
Product Code DRA
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
K112239
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Literature
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 11/06/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/16/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberUNK SGC
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received10/17/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age68 YR
Patient SexMale
Patient Weight60 KG
-
-